EFFICACY AND SAFETY OF ECULIZUMAB IN CHILDREN AND ADOLESCENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

被引：0
|
作者：
Reiss, U. [1 ]
Schwartz, J. [2 ]
Puthenveetil, G. [3 ]
Ogawa, M. [4 ]
Ware, R. [5 ]
机构：
[1] St Jude Childrens Res Hosp, Memphis, TN 38105 USA
[2] Nemours Childrens Clin, Pensacola, FL USA
[3] Childrens Hosp Orange Cty, Dept Pediat, Orange, CA 92668 USA
[4] Alexion Pharmaceut Inc, Cheshire, CA USA
[5] Texas Childrens Hematol Ctr, Houston, TX USA
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0897
引用
收藏
页码：370 / 371
页数：2
相关论文
共 50 条
  • [41] The Importance of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria: A Cohort Study
    Yenerel, Mustafa Nuri
    Erdem, Simge
    Mastanzade, Metban
    Nalcaci, Meliha
    [J]. BLOOD, 2018, 132
  • [42] Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS Clinical Trial
    Kanakura, Yuzuru
    Ohyashiki, Kazuma
    Shichishima, Tsutomu
    Okamoto, Shinichiro
    Ando, Kiyoshi
    Ninomiya, Haruhiko
    Kawaguchi, Tatsuya
    Nakao, Shinji
    Nakakuma, Hideki
    Nishimura, Jun-ichi
    Kinoshita, Taroh
    Bedrosian, Camille L.
    Valentine, Marye Ellen
    Khursigara, Gus
    Ozawa, Keiya
    Omine, Mitsuhiro
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (01) : 36 - 46
  • [43] Paroxysmal nocturnal hemoglobinuria in children
    Van Den Heuvel-Eibrink M.M.
    [J]. Pediatric Drugs, 2007, 9 (1) : 11 - 16
  • [44] Pegcetacoplan in paroxysmal nocturnal hemoglobinuria: A systematic review on efficacy and safety
    Shah, Sangam
    Chamlagain, Rajan
    Musalman, Ziyaul Haq
    Adhikari, Yagya Raj
    Chhetri, Santosh
    Paudel, Sujan
    Gundabolu, Krishna
    Dhakal, Prajwal
    [J]. RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2022, 6 (05)
  • [45] Long-Term Safety of Sustained Eculizumab Treatment in Patients with Paroxysmal Nocturnal Hemoglobinuria
    Szer, Jeffrey
    Muus, Petra
    Roeth, Alexander
    Elebute, M. O.
    Risitano, Antonio M.
    Schrezenmeier, Hubert
    Maciejewski, Jaroslaw P.
    Urbano-Ispizua, Alvaro
    de Castro, Carlos Manuel, III
    Socie, Gerard
    Brodsky, Robert A.
    [J]. BLOOD, 2012, 120 (21)
  • [46] Evaluating ravulizumab for the treatment of children and adolescents with paroxysmal nocturnal hemoglobinuria
    Yoo, Justin J.
    Chonat, Satheesh
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2022, 15 (05) : 385 - 392
  • [47] Efficacy and Safety at 48 Weeks of Pegcetacoplan in Adult Paroxysmal Nocturnal Hemoglobinuria Patients with Suboptimal Response to Prior Eculizumab Treatment
    Weitz, Ilene C.
    de Latour, Regis Peffault
    Szer, Jeffrey
    Roth, Alexander
    Hochsmann, Britta
    Panse, Jens
    Usuki, Kensuke
    Griffin, Morag
    Kiladjian, Jean-Jacques
    de Castro, Carlos M.
    Nishimori, Hisakazu
    Tan, Lisa
    Al-Adhami, Mohammed
    Deschatelets, Pascal
    Francois, Cedric
    Grossi, Federico
    Risitano, Antonio
    Hillmen, Peter
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S341 - S342
  • [48] Vaccination of patients with paroxysmal nocturnal hemoglobinuria under eculizumab treatment
    Rodriguez-Garcia, Juan
    Fernandez-Santos, Rafael
    Antonio Garcia-Erce, Jose
    [J]. MEDICINA CLINICA, 2012, 138 (14): : 640 - 641
  • [49] Eculizumab opens a new era of treatment for paroxysmal nocturnal hemoglobinuria
    Schrezenmeier, Hubert
    Hoechsmann, Britta
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2009, 2 (01) : 7 - 16
  • [50] Treatment of paroxysmal nocturnal hemoglobinuria in pregnancy with eculizumab: A case report
    Fassett, Michael J.
    Lopez, Adrian L. Hernandez
    [J]. CASE REPORTS IN WOMENS HEALTH, 2021, 30
12345